Received Apr 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (NOVAVAX)) | NOVAVAX | 4 | 6024MF025 | IM / AR |
acute pancreatitis, 3-4 hours after booster had onset of severe epigastric abdominal pain with associated nausea without vomiting. Only PO intake was a soda pop and some candy. abnormal CBC noted in ED
none
long-COVID syndrome, moderate persistent asthma, dyslipidemia, constipation, depression, overweight (BMI 29.7)
albuterol 108mcg/act PRN, amantadine 100mg BID, budesonide-formoterol 160-4.5 mcg/act BID, desonide 0.05% cream PRN, ketoconazole 2% shampoo PRN, naltrexone 4.5mg daily, montelukast 10mg, propanolol 10mg TID, alpha-lipoic acid 300mg daily,
penicillin - anaphylaxis
3/29/25 Lipase 3,803; CMP with Cr 1.36 and ALP 102 otherwise normal; CBC with WBC 11.1 (K/mcl), elevated eosinophils (absolute count 1.83K/mcl) and basophils (absolute count 0.43 K/mcl) with polychromasia 1+ on diff; Lactate 0.7; 10/3/22 lipid panel with TG 129, LDL 102, HDL 36, TC 164